Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia

Details for Australian Patent Application No. 2002214165 (hide)

Owner AstraZeneca AB

Inventors Raza, Ali; Hutchinson, Howard Gerard

Agent Davies Collison Cave

Pub. Number AU-B-2002214165

PCT Pub. Number WO02/41895

Priority 0028429 22.11.00 GB

Filing date 16 November 2001

Wipo publication date 3 June 2002

Acceptance publication date 14 December 2006

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

14 December 2006 Application Accepted

  Published as AU-B-2002214165

19 April 2007 Standard Patent Sealed

22 December 2011 Licence Registered

  AstraZeneca AB ( AstraZeneca Pty Limited )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002214166

2002214164-AN AIR-VENTILATOR WITH HIGH EFFICIENCY THERMAL EXCHANGER AND AIR FILTER